SELECT ISSUE

Romanian Journal of Rheumatology, Volume XXIII, No. 1, 2014
ISSN 1843-0791  |  e-ISSN 2069-6086
ISSN-L 1843-0791
DOI: 10.37897/RJR

Indexed

DOI - Crossref
Similarity Check by iThenticate, worldwide No 1 professional plagiarism checking system
DOAJ
Scopus
NLM Catalog
Ebsco Host - Medline
Google Academic
Semantic Scholar

HIGHLIGHTS

National Awards “Science and Research”

NEW! RJR has announced the annually National Award for "Science and Research" for the best scientific articles published throughout the year in the official journal.

ICMJE- Recommendations

Read the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly work in Medical Journals.

Promoting Global Health

The published medical research literature is a global public good. Medical journal editors have a social responsibility to promote global health by publishing, whenever possible, research that furthers health worldwide.

CONSIDERATIONS ABOUT BIOLOGIC TREATMENT WITHDRAWAL IN PATIENTS WITH JUVENILE IDIOPATHIC ARTHRITIS AFTER DISEASE REMISSION

ABSTRACT

The aim of this paper is to discuss the reasons and opportunities for tapering and discontinuing treatment with biological agents when the clinical remission of juvenile idiopathic arthritis (JIA) is achieved. Unfortunately, the few studies published recently on JIA focused almost exclusively on etanercept and had conflicting results. It appears that the relapse rates after termination of these medications is substantial. No predictors of the risk of flare were identified. Currently, the role of Doppler ultrasound in the assessment of the status of JIA (activity/remission) has not been fully established. The optimal timeline for withdrawal after documentation of remission, as much as the modality of discontinuation, also remain to be established. The lack of evidence-based data from randomized controlled clinical trials imposes a pressing need to create guidelines for treatment discontinuation.

Keywords: JIA, biological treatment, withdrawal

Full text | PDF